Shahab Uddin
King Faisal Specialist Hospital and Research Center
Riyadh
Saudi Arabia
Name/email consistency: high
- Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Uddin, S., Ahmed, M., Hussain, A., Assad, L., Al-Dayel, F., Bavi, P., Al-Kuraya, K.S., Munkarah, A. Int. J. Cancer (2010)
- Developing curcumin into a viable therapeutic for lymphoma. Uddin, S., Khan, A.S., Al-Kuraya, K.S. Expert. Opin. Investig. Drugs (2009)
- Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Uddin, S., Hussain, A.R., Siraj, A.K., Manogaran, P.S., Al-Jomah, N.A., Moorji, A., Atizado, V., Al-Dayel, F., Belgaumi, A., El-Solh, H., Ezzat, A., Bavi, P., Al-Kuraya, K.S. Blood (2006)
- Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin, S., Hussain, A.R., Al-Hussein, K.A., Manogaran, P.S., Wickrema, A., Gutierrez, M.I., Bhatia, K.G. Clin. Cancer Res. (2005)
- Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Uddin, S., Hussain, A.R., Manogaran, P.S., Al-Hussein, K., Platanias, L.C., Gutierrez, M.I., Bhatia, K.G. Oncogene (2005)
- Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. Uddin, S., Hussain, A., Al-Hussein, K., Platanias, L.C., Bhatia, K.G. Biochem. Biophys. Res. Commun. (2004)
- Mechanisms of type-I interferon signal transduction. Uddin, S., Platanias, L.C. J. Biochem. Mol. Biol. (2004)









